The Kromek Group plc is listed on London’s Alternative Investment Market, AIM. Its ordinary shares carry the symbol KMK-L. Kromek Group plc is incorporated in England and Wales under the Companies Act 2006 (registration number 8661469). With facilities in the UK and US, Kromek sells internationally with partnerships and distribution channels in Asia, Europe, and North America, to a global customer base.
This section was last updated on 26 September 2019.
26/09/2019 Results of AGM
24/09/2019 Kromek awarded two contracts for D3S products.
30/08/2019 Notice of AGM and publication of the annual report.
01/07/2019 New contracts for D3S platform.
27/06/2019 Final Results for the Year ended 30th April 2019
07/05/2019 Kromek trading update.
01/05/2019 Security screening contract expansion.
29/03/2019 Change of Adviser.
18/03/2019 Director Dealings Correction.
28/02/2019 TR-1 Canaccord Genuity
28/02/2019 TR-1 Killik & Co
28/02/2019 TR-1 Miton Diverse Income Trust
28/02/2019 TR-1 Miton Group
28/02/2019 TR-1 Miton UK Microcap Trust
26/02/2019 Directors Dealings 26.02.19.
26/02/2019 Kromek contract with new OEM for nuclear security.
25/02/2019 Results of General Meeting and Open Offer and Total Voting Rights
07/02/2019 Firm Placing and Open Offer to raise up to £21 million and Notice of General Meeting.
31/01/2019 Total Voting Rights
28/01/2019 Kromek awarded $58M medical imaging contract.
14/01/2019 Kromek Interim Results 2018-19
